LENZ logo

LENZ Therapeutics, Inc. (LENZ) Cash from financing

annual CFF:

$199.00M+$118.30M(+146.59%)
December 31, 2024

Summary

  • As of today (September 16, 2025), LENZ annual cash flow from financing activities is $199.00 million, with the most recent change of +$118.30 million (+146.59%) on December 31, 2024.
  • During the last 3 years, LENZ annual CFF has fallen by -$218.47 million (-52.33%).
  • LENZ annual CFF is now -52.33% below its all-time high of $417.47 million, reached on December 1, 2021.

Performance

1-year change

+146.59%

3-year change

-52.33%

5-year change

+100%

15-year change

+100%

LENZ Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

89.88%
LENZ annual cash flow from financing activities is higher than 89.88% of companies in Healthcare sector

Range

All-time high

$417.47M
LENZ annual cash flow from financing activities is currently -52.33% below its historical high of $417.47 million

3-year low

$597.00K
LENZ annual cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
LENZ previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
LENZ next annual earnings announcement has not yet been scheduled

OtherLENZcash flow metrics

annual CFI

-$154.48M
LENZ annual cash flow from investing activities is -$154.48 million

annual CFO

-$59.39M
LENZ annual cash flow from operations is -$59.39 million

annual FCF

-$59.86M
LENZ annual free cash flow is -$59.86 million

annual CAPEX

$468.00K
LENZ annual capital expenditures is $468.00 thousand

quarterly CFF:

$26.49M+$26.44M(+60100.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), LENZ quarterly cash flow from financing activities is $26.49 million, with the most recent change of +$26.44 million (+60100.00%) on June 30, 2025.
  • LENZ quarterly CFF is now -87.93% below its all-time high of $219.50 million, reached on June 1, 2021.

Performance

3-month change

+60100%

1-year change

-

3-year change

+6329.13%

5-year change

+76.61%

LENZ quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

92.28%
LENZ quarterly cash flow from financing activities is higher than 92.28% of companies in Healthcare sector

Range

All-time high

$219.50M
LENZ quarterly cash flow from financing activities is currently -87.93% below its historical high of $219.50 million

3-year low

-$1.91M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
LENZ previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 29, 2025
LENZ next earnings announcement is scheduled for Oct 29, 2025

OtherLENZcash flow metrics

quarterly CFI

-$414.00K
LENZ quarterly cash flow from investing activities is -$414.00 thousand

quarterly CFO

-$11.51M
LENZ quarterly cash flow from operations is -$11.51 million

quarterly FCF

-$11.75M
LENZ quarterly free cash flow is -$11.75 million

quarterly CAPEX

$240.00K
LENZ quarterly capital expenditures is $240.00 thousand

TTM CFF:

$56.40M+$26.49M(+88.54%)
June 30, 2025

Summary

  • As of today (September 16, 2025), LENZ TTM cash flow from financing activities is $56.40 million, with the most recent change of +$26.49 million (+88.54%) on June 30, 2025.
  • LENZ TTM CFF is now -86.95% below its all-time high of $432.27 million, reached on September 1, 2021.

Performance

3-month change

+88.54%

1-year change

-

3-year change

+72.94%

5-year change

+277.13%

LENZ TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

80.92%
LENZ TTM cash flow from financing activities is higher than 80.92% of companies in Healthcare sector

Range

All-time high

$432.27M
LENZ TTM cash flow from financing activities is currently -86.95% below its historical high of $432.27 million

3-year low

$589.00K
LENZ TTM cash flow from financing activities is currently +9476.06% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
LENZ previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 29, 2025
LENZ next earnings announcement is scheduled for Oct 29, 2025

OtherLENZcash flow metrics

TTM CFI

-$55.61M
LENZ TTM cash flow from investing activities is -$55.61 million

TTM CFO

-$47.22M
LENZ TTM cash flow from operations is -$47.22 million

TTM FCF

-$47.90M
LENZ TTM free cash flow is -$47.90 million

TTM CAPEX

$685.00K
LENZ TTM capital expenditures is $685.00 thousand

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

LENZ Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+146.6%--
3 y3 years-52.3%+6329.1%+72.9%
5 y5 years+100.0%+76.6%+277.1%

LENZ Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-52.3%>+9999.0%-68.2%+1486.1%-32.3%+9476.1%
5 y5-year-52.3%>+9999.0%-87.9%+1486.1%-87.0%+9476.1%
alltimeall time-52.3%>+9999.0%-87.9%+1486.1%-87.0%>+9999.0%

LENZ Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$26.49M(>+9900.0%)
$56.40M(+88.5%)
Mar 2025
-
$44.00K(-17.0%)
$29.91M(+0.1%)
Dec 2024
$199.00M(+146.6%)
$53.00K(-99.8%)
$29.87M(+7.0%)
Sep 2024
-
$29.82M(-1660.3%)
$27.91M(-65.4%)
Dec 2023
$80.70M(>+9900.0%)
-$1.91M(+236.4%)
$80.70M(-2.6%)
Sep 2023
-
-$568.00K(-100.7%)
$82.86M(-0.6%)
Jun 2023
-
$83.19M(<-9900.0%)
$83.36M(>+9900.0%)
Mar 2023
-
-$8000.00(-103.3%)
$589.00K(-1.3%)
Dec 2022
$597.00K
-
-
Dec 2022
-
$244.00K(-513.6%)
$597.00K(-10.4%)
Sep 2022
-
-$59.00K(-114.3%)
$666.00K(-98.0%)
DateAnnualQuarterlyTTM
Jun 2022
-
$412.00K(>+9900.0%)
$32.62M(-87.0%)
Mar 2022
-
$0.00(-100.0%)
$251.70M(-39.7%)
Dec 2021
$417.47M(+1288.0%)
$313.00K(-99.0%)
$417.47M(-3.4%)
Sep 2021
-
$31.89M(-85.5%)
$432.27M(+8.0%)
Jun 2021
-
$219.50M(+32.4%)
$400.34M(+104.4%)
Mar 2021
-
$165.77M(+996.3%)
$195.84M(+551.1%)
Dec 2020
$30.08M(>+9900.0%)
$15.12M(<-9900.0%)
$30.08M(+101.1%)
Sep 2020
-
-$42.00K(-100.3%)
$14.96M(-0.3%)
Jun 2020
-
$15.00M(>+9900.0%)
$15.00M(>+9900.0%)
Mar 2020
-
$0.00
$0.00
Dec 2019
$0.00
-
-

FAQ

  • What is LENZ Therapeutics, Inc. annual cash flow from financing activities?
  • What is the all time high annual CFF for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. annual CFF year-on-year change?
  • What is LENZ Therapeutics, Inc. quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. TTM cash flow from financing activities?
  • What is the all time high TTM CFF for LENZ Therapeutics, Inc.?

What is LENZ Therapeutics, Inc. annual cash flow from financing activities?

The current annual CFF of LENZ is $199.00M

What is the all time high annual CFF for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high annual cash flow from financing activities is $417.47M

What is LENZ Therapeutics, Inc. annual CFF year-on-year change?

Over the past year, LENZ annual cash flow from financing activities has changed by +$118.30M (+146.59%)

What is LENZ Therapeutics, Inc. quarterly cash flow from financing activities?

The current quarterly CFF of LENZ is $26.49M

What is the all time high quarterly CFF for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $219.50M

What is LENZ Therapeutics, Inc. TTM cash flow from financing activities?

The current TTM CFF of LENZ is $56.40M

What is the all time high TTM CFF for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high TTM cash flow from financing activities is $432.27M
On this page